Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Uniontown › NPI 1871594127
Hospital

Uniontown Hospital

Uniontown Hospital was paid $14.46M by Medicaid between Jan 2018 and Dec 2024, across 368 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.

33Billing provider infoUNIONTOWN HOSPITAL
UNIONTOWN, PA 15401
33aNPI1871594127assigned 08/09/2005
28Total paid$14.46M
24GClaims570,567
24DCodes billed368
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#22 of 154
Median peer was paid$2.82M
This provider vs. median5.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018644$14K
2019357$6K
202044,928$996K
2021231,965$5.80M
2022101,137$2.44M
2023108,570$2.65M
2024incomplete82,966$2.55M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 21,854 21,186 $2.60M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 22,866 22,289 $1.87M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 10,242 9,865 $1.66M
G0378 Hospital observation service, per hour 3.7% 1,969 1,253 $532K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.3% 5,191 5,060 $479K
80053 Comprehensive metabolic panel 3.1% 43,313 40,546 $441K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.9% 2,356 2,290 $426K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.6% 3,745 3,661 $371K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.4% 12,022 11,425 $342K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.7% 46,966 42,903 $246K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.6% 6,142 6,036 $236K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.6% 6,538 6,231 $235K
356 more codes
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.4% 483 $197K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 2,096 $186K
70450 Computed tomography, head or brain; without contrast material 1.2% 2,740 $174K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 18,074 $163K
80061 Lipid panel 1.1% 11,974 $161K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,194 $135K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 720 $132K
84443 Thyroid stimulating hormone (TSH) <1% 6,922 $127K
80050 General health panel <1% 2,377 $123K
96375 Therapeutic injection; each additional sequential IV push <1% 6,394 $114K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,174 $111K
71275 Computed tomographic angiography, chest, with contrast material <1% 545 $108K
71045 Radiologic examination, chest; single view <1% 14,050 $106K
84484 <1% 10,821 $98K
83735 <1% 13,572 $85K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 299 $83K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,069 $78K
72141 <1% 304 $73K
77067 Screening mammography, bilateral, including computer-aided detection <1% 808 $68K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 251 $63K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,104 $61K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,778 $58K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,933 $54K
99213 Doctor's office visit, returning patient (routine) <1% 1,827 $53K
97597 <1% 2,231 $51K
80048 Basic metabolic panel (calcium, ionized) <1% 6,695 $50K
85730 <1% 8,015 $48K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 776 $48K
83690 <1% 8,915 $43K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,539 $43K
85027 <1% 6,733 $42K
74178 <1% 203 $42K
71046 Radiologic examination, chest; 2 views <1% 2,848 $41K
81001 <1% 13,606 $39K
83036 Hemoglobin; glycosylated (A1C) <1% 5,500 $37K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 993 $36K
12001 <1% 189 $34K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,350 $33K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,198 $33K
47562 <1% 40 $33K
85610 <1% 9,945 $32K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 198 $32K
72125 Computed tomography, cervical spine; without contrast material <1% 496 $31K
71250 <1% 512 $31K
93971 <1% 456 $30K
83880 <1% 1,080 $29K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 81 $27K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 362 $25K
74183 <1% 55 $24K
73221 <1% 93 $23K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 724 $23K
96361 Intravenous infusion, hydration; each additional hour <1% 2,325 $23K
82607 <1% 1,929 $23K
76536 <1% 460 $22K
82550 <1% 3,797 $22K
78227 <1% 69 $22K
76830 Ultrasound, transvaginal <1% 457 $22K
87088 <1% 2,996 $22K
86803 <1% 1,054 $21K
77066 Tomosynthesis, mammo <1% 241 $20K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,435 $20K
73562 <1% 1,255 $20K
70486 <1% 261 $20K
82248 <1% 2,740 $19K
70551 Magnetic resonance imaging, brain; without contrast material <1% 81 $18K
84703 <1% 1,665 $18K
72110 <1% 866 $18K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 364 $18K
76770 <1% 453 $18K
77063 Screening digital breast tomosynthesis, bilateral <1% 769 $17K
87186 <1% 1,581 $17K
93970 <1% 197 $16K
87040 <1% 852 $16K
83605 <1% 2,282 $16K
12011 <1% 84 $16K
82728 <1% 1,304 $16K
36415 Collection of venous blood by venipuncture <1% 46,375 $15K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 564 $15K
93925 <1% 167 $15K
81025 <1% 3,754 $14K
84436 <1% 1,998 $14K
84702 <1% 795 $14K
20610 <1% 881 $14K
73030 <1% 883 $14K
83540 <1% 1,566 $14K
80081 <1% 138 $13K
52000 <1% 98 $13K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 555 $13K
93880 <1% 185 $13K
76642 <1% 297 $12K
82553 <1% 1,618 $12K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 128 $12K
93017 <1% 360 $12K
99203 Doctor's office visit, new patient (routine) <1% 296 $12K
84153 <1% 493 $12K
83970 <1% 289 $12K
82043 <1% 1,417 $11K
81003 <1% 3,900 $11K
94729 <1% 396 $11K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 221 $11K
87077 <1% 1,588 $11K
73564 <1% 498 $11K
86704 <1% 639 $11K
86787 <1% 362 $11K
73610 <1% 564 $10K
84402 <1% 329 $10K
86708 <1% 623 $10K
84403 <1% 325 $10K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,892 $10K
73560 <1% 651 $10K
94726 <1% 378 $10K
73502 <1% 536 $10K
86706 <1% 657 $10K
84439 <1% 1,161 $10K
72131 <1% 152 $10K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 169 $9K
80076 <1% 958 $9K
36430 <1% 146 $9K
85379 <1% 878 $9K
87340 <1% 632 $8K
51798 <1% 1,014 $8K
73630 <1% 653 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 364 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 457 $8K
82747 <1% 316 $8K
84146 <1% 267 $8K
78264 <1% 83 $7K
82570 <1% 981 $7K
72100 <1% 359 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,008 $7K
82805 <1% 259 $7K
71271 <1% 81 $7K
87522 Neg quan hep c or qual rna <1% 162 $7K
10060 <1% 53 $7K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 298 $7K
12002 <1% 39 $7K
73130 <1% 553 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 298 $7K
87070 <1% 987 $6K
90715 <1% 989 $6K
83550 <1% 1,304 $6K
72050 <1% 261 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,573 $6K
84460 <1% 785 $6K
82784 <1% 292 $6K
83001 <1% 283 $6K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 234 $6K
84479 <1% 615 $6K
74018 <1% 407 $6K
81596 <1% 109 $6K
82803 <1% 221 $6K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 300 $6K
82746 <1% 792 $5K
86617 <1% 183 $5K
84450 <1% 755 $5K
87081 <1% 845 $5K
72072 <1% 229 $5K
86038 <1% 395 $5K
J2785 Injection, regadenoson, 0.1 mg <1% 153 $5K
83002 <1% 230 $5K
93226 <1% 121 $4K
70498 <1% 26 $4K
86762 <1% 203 $4K
70496 <1% 25 $4K
86850 <1% 600 $4K
82565 <1% 643 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 59 $4K
73110 <1% 319 $4K
76775 <1% 102 $4K
77062 <1% 198 $4K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 495 $4K
94060 <1% 340 $4K
82150 <1% 751 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 58 $3K
86780 <1% 248 $3K
84466 <1% 179 $3K
70491 <1% 44 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 627 $3K
73590 <1% 182 $3K
83655 <1% 247 $3K
84550 <1% 444 $3K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 884 $3K
80164 <1% 151 $3K
86003 <1% 14 $3K
86900 <1% 681 $3K
87807 <1% 173 $3K
76870 <1% 52 $3K
86901 <1% 679 $2K
82105 <1% 121 $2K
84145 <1% 160 $2K
87581 <1% 521 $2K
84520 <1% 476 $2K
87205 <1% 492 $2K
72146 <1% 13 $2K
94760 <1% 1,425 $2K
73080 <1% 191 $2K
86140 <1% 726 $2K
82670 <1% 87 $2K
72040 <1% 145 $2K
86431 <1% 247 $2K
84481 <1% 86 $2K
P9016 Red blood cells, leukocytes reduced, each unit <1% 49 $2K
82950 <1% 273 $2K
85652 <1% 700 $2K
84100 <1% 460 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 86 $2K
93225 <1% 121 $2K
88112 <1% 46 $2K
77065 Tomosynthesis, mammo <1% 32 $2K
20553 <1% 63 $2K
82977 <1% 172 $2K
96367 <1% 229 $2K
97602 <1% 75 $2K
85651 <1% 455 $2K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 239 $2K
86618 <1% 54 $2K
77080 <1% 30 $2K
82627 <1% 60 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 449 $2K
82172 <1% 67 $1K
73090 <1% 117 $1K
82140 <1% 323 $1K
73600 <1% 113 $1K
73552 <1% 75 $1K
85018 <1% 356 $1K
86592 <1% 315 $1K
87430 <1% 175 $1K
29581 <1% 130 $1K
83010 <1% 72 $963.84
99215 Doctor's office visit, returning patient (complex) <1% 54 $953.79
Q9957 Injection, perflutren lipid microspheres, per ml <1% 59 $945.87
80177 <1% 77 $912.82
84156 <1% 218 $910.87
73100 <1% 74 $903.04
73140 <1% 100 $901.98
83525 <1% 70 $899.91
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 200 $878.00
82947 <1% 183 $858.74
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 24 $830.92
93976 <1% 12 $820.73
J2805 Injection, sincalide, 5 micrograms <1% 26 $807.99
87147 <1% 154 $772.27
87209 <1% 44 $749.72
85014 <1% 228 $747.95
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,428 $728.24
87045 <1% 96 $726.26
C1889 Implantable/insertable device, not otherwise classified <1% 57 $712.47
80179 <1% 181 $709.32
80143 <1% 183 $709.32
80069 <1% 60 $671.25
82247 <1% 102 $642.50
83516 <1% 209 $624.17
96376 <1% 848 $603.95
72170 <1% 71 $578.91
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 174 $564.82
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,485 $558.56
87046 <1% 51 $548.19
93296 <1% 93 $544.71
73120 <1% 53 $537.70
73522 <1% 27 $531.94
73620 <1% 47 $519.13
82785 <1% 27 $506.52
62323 <1% 12 $485.99
85045 <1% 120 $483.64
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 389 $480.89
J2704 Injection, propofol, 10 mg <1% 2,846 $468.01
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,859 $454.88
80051 <1% 94 $448.64
72202 <1% 26 $430.94
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,051 $414.76
82010 <1% 102 $409.10
86920 <1% 14 $382.83
74230 <1% 29 $380.36
86308 <1% 48 $372.73
87177 <1% 44 $370.41
83615 <1% 58 $368.34
73060 <1% 26 $363.48
74022 <1% 13 $359.04
86696 <1% 12 $356.31
20552 <1% 12 $310.64
82272 <1% 98 $304.49
29125 <1% 17 $297.37
86695 <1% 12 $285.10
77061 <1% 15 $283.20
86039 <1% 16 $278.40
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,035 $263.90
94761 <1% 104 $256.10
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 68 $232.00
93922 <1% 17 $227.10
73501 <1% 27 $223.07
94010 <1% 31 $220.22
J0780 Injection, prochlorperazine, up to 10 mg <1% 156 $215.17
82951 <1% 14 $213.16
84480 <1% 28 $212.49
86200 <1% 13 $201.16
83883 <1% 88 $199.20
87808 <1% 15 $199.14
85046 <1% 32 $198.51
71101 <1% 12 $195.87
36600 <1% 45 $195.40
J1170 Injection, hydromorphone, up to 4 mg <1% 440 $183.25
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 107 $181.20
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,237 $174.23
J3370 Injection, vancomycin hcl, 500 mg <1% 160 $170.88
92611 <1% 12 $158.26
83520 <1% 45 $139.04
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 199 $135.15
97162 <1% 32 $121.60
90714 <1% 33 $119.80
88304 <1% 300 $112.29
J1650 Injection, enoxaparin sodium, 10 mg <1% 458 $106.98
86376 <1% 13 $97.66
97165 <1% 97 $95.16
J2060 Injection, lorazepam, 2 mg <1% 590 $94.99
97161 <1% 112 $92.51
84132 <1% 14 $90.63
J3475 Injection, magnesium sulfate, per 500 mg <1% 602 $81.10
J0690 Injection, cefazolin sodium, 500 mg <1% 807 $79.19
95992 <1% 67 $78.10
87075 <1% 19 $74.41
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 116 $73.64
87324 <1% 51 $70.16
J1644 Injection, heparin sodium, per 1000 units <1% 580 $66.77
87015 <1% 23 $65.78
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,557 $63.98
82077 <1% 15 $53.15
J1953 Injection, levetiracetam, 10 mg <1% 14 $52.56
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 221 $51.50
J2550 Injection, promethazine hcl, up to 50 mg <1% 63 $37.28
99152 <1% 13 $34.16
81015 <1% 13 $28.14
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,438 $27.66
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 68 $23.10
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,466 $22.34
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 135 $16.53
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 12 $14.26
88300 <1% 51 $13.26
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 15 $11.70
J1940 Injection, furosemide, up to 20 mg <1% 143 $10.48
82962 <1% 29 $4.74
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 181 $3.81
J1630 Injection, haloperidol, up to 5 mg <1% 13 $2.86
J7510 Prednisolone oral, per 5 mg <1% 14 $2.13
J7050 Infusion, normal saline solution, 250 cc <1% 12 $0.76
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 507 $0.55
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 272 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 210 $0.00
90675 0% 31 $0.00
J0888 Injection, epoetin beta, 1 microgram, (for non esrd use) 0% 15 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 12 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 89 $0.00
G0475 Hiv antigen/antibody, combination assay, screening 0% 12 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 122 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 34 $0.00
74420 0% 15 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHANDY, STEVEN (VP - CFO/CIO)